Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leucovorin in children with autism spectrum disorder (Chinese Han population)
ChiCTR2100050018Phase 4Recruiting
- Sponsor
- Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University
- Start
- Jul 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of folinic acid in Autism Spectrum Disorder (ASD) (2 arms), sponsored by Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University. Primary endpoints: Psychoeducational Profile (Third Edition) (PEP-3) at 12 weeks and Autism Treatment Evaluation Checklist (ATEC) at 12 weeks. Started Jul 2021; status: recruiting.
02
Drugs
folinic acid
03
Conditions
Autism Spectrum Disorder (ASD)
Beyond the preview
Go deeper on ChiCTR2100050018.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100050018.